Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)

Published:2015-12-24 Issue:3 Volume:48 Page:869-885
ISSN:1019-6439
Container-title:International Journal of Oncology
language:en
Short-container-title:

Author:

NITULESCU GEORGE MIHAI,MARGINA DENISA,JUZENAS PETRAS,PENG QIAN,OLARU OCTAVIAN TUDOREL,SALOUSTROS EMMANOUIL,FENGA CONCETTINA,SPANDIDOS DEMETRIOS A.,LIBRA MASSIMO,TSATSAKIS ARISTIDIS M.

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 312 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis and biological evaluation of a new series of imidazothiazole-hydrazone hybrids as dual EGFR and Akt inhibitors for NSCLC therapy;European Journal of Medicinal Chemistry;2024-10

2. CRLF1 bridges AKT and mTORC2 through SIN1 to inhibit pyroptosis and enhance chemo-resistance in ovarian cancer;Cell Death & Disease;2024-09-10

3. Exploring Radioiodinated Anastrozole and Epirubicin as AKT1-Targeted Radiopharmaceuticals in Breast Cancer: In Silico Analysis and Potential Therapeutic Effect with Functional Nuclear Imagining Implications;Molecules;2024-09-04

4. Targeting the RAS upstream and downstream signaling pathway for cancer treatment;European Journal of Pharmacology;2024-09

5. Combination of transcriptomic and proteomic approaches helps unravel the mechanisms of luteolin in inducing liver cancer cell death via targeting AKT1 and SRC;Frontiers in Pharmacology;2024-08-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP